Skip to content
The Longevity Archive
Foselutoclax in all countries

Legal status · Australia

Is Foselutoclax legal in Australia?

InvestigationalLongevityEvidence: Moderate

No. Foselutoclax is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Foselutoclax in Australia at a glance

ClassificationInvestigational, not registered
TGA approval statusNot approved by TGA; investigational
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Foselutoclax profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    Foselutoclax is being studied in registered clinical trials but has not received TGA marketing approval in Australia.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Foselutoclax is

The most advanced senolytic in humans: an injected BCL-xL inhibitor that matched the biologic aflibercept on vision at most timepoints in a Phase 2b for diabetic macular edema.

Foselutoclax (Unity Biotechnology) kills senescent cells by blocking BCL-xL, the survival protein those cells depend on. Given as an eye injection, it improved vision by 5 or more letters at weeks 24 and 36 in the ASPIRE Phase 2b and was non-inferior to aflibercept at 9 of 10 timepoints, though investors judged the result mixed.

Mechanism: Inhibition of BCL-xL removes the anti-apoptotic signal senescent cells rely on, inducing their selective death.

Regulatory history: Investigational; Phase 2b

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Foselutoclax at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Foselutoclax in other countries

Frequently asked questions

Is Foselutoclax legal in Australia?

No. Foselutoclax is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Foselutoclax in Australia?

No approved product exists to buy. In Australia Foselutoclax is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Foselutoclax TGA approved?

No. In Australia Foselutoclax is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational; Phase 2b. Evidence level: Moderate.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Foselutoclax live on its compound profile.

Foselutoclax profile

This page is general information about the regulatory status of Foselutoclax in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.